摘要
目的:观察醒脾养儿颗粒治疗小儿原发性夜间遗尿症的疗效和安全性。方法:97例原发性夜间遗尿症患儿随机分为对照组(46例)和观察组(51例)。对照组患儿给予消旋山莨菪碱片0.5 mg/(kg·d),口服,每日1次+维生素B1片10 mg,口服,每日3次+谷维素片10 mg,口服,每日3次+睡前30 min口服盐酸甲氯芬酯胶囊0.1 g,口服,每日1次。观察组患儿在对照组治疗的基础上加服醒脾养儿颗粒5~6岁0.4 g,7~14岁0.6 g,每日3次。两组均连续治疗4周。观察两组患儿的临床疗效,治疗前后肾阳虚症状积分、唤醒阈、膀胱容量、膀胱容量壁厚指数(BVWI)、遗尿频率、血清精氨酸加压素(AVP)、环磷酸腺苷(c AMP)、环磷酸鸟苷(c GMP)、c AMP/c GMP,复发率及不良反应发生情况。结果:观察组患儿总有效率显著高于对照组,差异有统计学意义(P<0.01)。治疗后,两组患儿肾阳虚症状积分、唤醒阈、BVWI、遗尿频率、血清c GMP均显著低于同组治疗前,且观察组显著低于对照组;两组患儿膀胱容量、血清AVP、c AMP、c AMP/c GMP均显著高于同组治疗前,且观察组显著高于对照组,差异均有统计学意义(P<0.01)。治疗3个月后,两组总有效患儿复发率比较,差异无统计学意义(P>0.05);治疗6个月后,观察组总有效患儿复发率显著低于对照组,差异有统计学意义(P<0.01)。两组患儿不良反应发生率比较,差异无统计学意义(P>0.05)。结论:在常规治疗的基础上,醒脾养儿颗粒治疗小儿原发性夜间遗尿症的疗效和安全性均较好,可改善患儿肾阳虚症状及唤醒阈,提高患儿的膀胱容量和血清AVP。
OBJECTIVE:To observe the efficacy and safety of Xingpi yang'er granule in the treatment of primary nocturnal enuresis in children. METHODS:97 children with primary nocturnal enuresis were randomly divided into control group(46 cases)and observation group(51 cases). Control group received Racemic anisodamine tablet 0.5 mg/(kg.d),orally,once a day+Vitamin B1 tablet 10 mg,orally,3 times a day+Oryzanol tablet 10 mg,orally,3 times a day + Meclofenac hydrochloride capsule 0.1 g 30 min before going to bed,orally,once a day. Observation group was additionally received Xingpi yang'er granule 0.4 g for 5-6years old and 0.6 g for 7-14 years old,3 times a day. They were treated for 4 weeks. Clinical efficacy,kidney Yang deficiency score,wake-up threshold,bladder capacity,bladder volume,BVWI,enuresis frequency,AVP,c AMP,c GMP,c AMP/c GMP before and after treatment,recurrence rate and the incidence of adverse reactions in 2 groups were observed. RESULTS:The total effective rate in observation group was significantly higher than control group(P〈0.01). After treatment,the kidney Yang deficiency score,wake-up threshold,BVWI,enuresis frequency and c GMP in 2 groups were significantly lower than before,and observation group was significantly lower than control group;bladder capacity,serum AVP,c AMP and c AMP/c GMP in 2 groups were significantly higher than before,and observation group was significantly higher than control group(P〉0.01). After 3 months,there was no significant difference in the recurrence rate in total effective children(P〈0.05);after 6 months,the total effective rate recurrence rate in observation group was significantly lower than control group(P〈0.01). And there was no significant difference in the incidence of adverse reactions(P〉0.05). CONCLUSIONS:Based on conventional treatment,Xingpi yang'er granule shows good efficacy and safety in the treatment of primary nocturnal enuresis in children,which can improve children's kidney Yang deficiency score,wake-up threshold and bladder capacity and serum AVP.
出处
《中国药房》
CAS
北大核心
2017年第6期738-741,共4页
China Pharmacy
基金
贵州省中医药
民族医药科学技术研究课题(No.QZYY2013-14)
黔南州科技计划项目(No.黔南科合字2013010)